Search research articles
Contact Us
Filters
Showing results (151-160 of 161) with videos related to
Page
of 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2002
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study
A von Rohr, S-F H Schmitz, A Tichelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
B C Pestalozzi, D Zahrieh, K N Price, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1997
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI
A Goldhirsch, R D Gelber, M Castiglione, et al.
British Journal of Cancer
|
November 17, 2004
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer
J Bernhard, D Zahrieh, A S Coates, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2017
Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
S K Metzelder, T Schroeder, M Lübbert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
G Gruber, B F Cole, M Castiglione-Gertsch, et al.
Bone Marrow Transplantation
|
July 22, 1999
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
E Vellenga, W L van Putten, M A Boogaerts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 1997
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia
B Löwenberg, M A Boogaerts, S M Daenen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
G Berclaz, S Li, K N Price, et al.
Leukemia
|
November 28, 2014
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years
J J Cornelissen, J Versluis, J R Passweg, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 161) with videos related to
Sort By:
Page
of 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2002
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study
A von Rohr, S-F H Schmitz, A Tichelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
B C Pestalozzi, D Zahrieh, K N Price, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1997
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI
A Goldhirsch, R D Gelber, M Castiglione, et al.
British Journal of Cancer
|
November 17, 2004
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer
J Bernhard, D Zahrieh, A S Coates, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2017
Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
S K Metzelder, T Schroeder, M Lübbert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
G Gruber, B F Cole, M Castiglione-Gertsch, et al.
Bone Marrow Transplantation
|
July 22, 1999
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
E Vellenga, W L van Putten, M A Boogaerts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 1997
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia
B Löwenberg, M A Boogaerts, S M Daenen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
G Berclaz, S Li, K N Price, et al.
Leukemia
|
November 28, 2014
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years
J J Cornelissen, J Versluis, J R Passweg, et al.
Page
of 17